Patents Examined by Philip C Edwards
  • Patent number: 11959497
    Abstract: Methods and apparatuses for determining operational parameters of a blood pump comprising a rotor which transports the blood are provided. The change in the behaviour of at least one first and one second operational parameter, independently from each other, of the pump, is determined. A determination of the flow through the pump and/or the difference in pressure across the pump and/or the viscosity of the blood takes into account the determined change in behaviour of the at least two operational parameters. A modelling for a dynamic model of the known quantities may be carried out and an estimation method using a Kalman filter may be used.
    Type: Grant
    Filed: June 28, 2021
    Date of Patent: April 16, 2024
    Assignee: Berlin Heart GmbH
    Inventors: Marcus Granegger, Robert Steingräber, Jonas Fabian Krone
  • Patent number: 11957906
    Abstract: This external stimulus application system is structured so as to comprise: an external stimulus unit that applies an external stimulus to a target area of a user's body; a detection unit that detects changes in a detected area of the user's body during an action of the user; a control unit that causes the external stimulus unit to produce a stimulus if a detected value detected by the detection unit satisfies a prescribed condition; and a storage unit that stores the detected value.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: April 16, 2024
    Assignee: Mitsui Chemicals, Inc.
    Inventors: Hidetoshi Tomita, Yuki Kondo, Motoyasu Yasui, Kenji Iida
  • Patent number: 11944820
    Abstract: Neurostimulation of a mixed nerve comprising a plurality of nerve fibre types. An implantable electrode array comprising a plurality of electrodes is positioned proximal to the mixed nerve. An electrical stimulus is delivered from at least one nominal stimulus electrode of the implantable electrode array, in accordance with a set of stimulus parameters. A recording of the electrophysiological response evoked by the electrical stimulus is obtained from at least one nominal recording electrode of the implantable electrode array. The recording is analysed by assessing one or more selected characteristics of the recording, and from the observed selected characteristics a level of recruitment of one or more fibre types recruited by the electrical stimulus is identified. The stimulus parameters are refined in a manner to effect selective recruitment of one or more fibre types relative to other fibre types of the mixed nerve.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: April 2, 2024
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Gerrit Eduard Gmel
  • Patent number: 11944802
    Abstract: A catheter pump is disclosed herein. The catheter pump can include a catheter assembly that comprises a drive shaft and an impeller coupled to a distal end of the drive shaft. A driven assembly can be coupled to a proximal end of the drive shaft within a driven assembly housing. The catheter pump can also include a drive system that comprises a motor and a drive magnet coupled to an output shaft of the motor. The drive system can include a drive assembly housing having at least one magnet therein. Further, a securement device can be configured to prevent disengagement of the driven assembly housing from the drive assembly housing during operation of the pump.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 2, 2024
    Assignee: TC1 LLC
    Inventors: Adam R. Tanner, Richard L. Keenan, Doug M. Messner, Michael R. Butler
  • Patent number: 11944801
    Abstract: A catheter pump is disclosed herein. The catheter pump can include a catheter assembly that comprises a drive shaft and an impeller coupled to a distal end of the drive shaft. A driven assembly can be coupled to a proximal end of the drive shaft within a driven assembly housing. The catheter pump can also include a drive system that comprises a motor and a drive magnet coupled to an output shaft of the motor. The drive system can include a drive assembly housing having at least one magnet therein. Further, a securement device can be configured to prevent disengagement of the driven assembly housing from the drive assembly housing during operation of the pump.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 2, 2024
    Assignee: TC1 LLC
    Inventors: Adam R. Tanner, Richard L. Keenan, Doug M. Messner, Michael R. Butler
  • Patent number: 11925796
    Abstract: A catheter pump is disclosed herein. The catheter pump can include a catheter assembly that comprises a drive shaft and an impeller coupled to a distal end of the drive shaft. A driven assembly can be coupled to a proximal end of the drive shaft within a driven assembly housing. The catheter pump can also include a drive system that comprises a motor and a drive magnet coupled to an output shaft of the motor. The drive system can include a drive assembly housing having at least one magnet therein. Further, a securement device can be configured to prevent disengagement of the driven assembly housing from the drive assembly housing during operation of the pump.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: March 12, 2024
    Assignee: TC1 LLC
    Inventors: Adam R. Tanner, Richard L. Keenan, Doug M. Messner, Michael R. Butler
  • Patent number: 11925797
    Abstract: A catheter pump is disclosed herein. The catheter pump can include a catheter assembly that comprises a drive shaft and an impeller coupled to a distal end of the drive shaft. A driven assembly can be coupled to a proximal end of the drive shaft within a driven assembly housing. The catheter pump can also include a drive system that comprises a motor and a drive magnet coupled to an output shaft of the motor. The drive system can include a drive assembly housing having at least one magnet therein. Further, a securement device can be configured to prevent disengagement of the driven assembly housing from the drive assembly housing during operation of the pump.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: March 12, 2024
    Assignee: TC1 LLC
    Inventors: Adam R. Tanner, Richard L Keenan, Doug M. Messner, Michael R. Butler
  • Patent number: 11911619
    Abstract: The present disclosure provides a method and system for treating affective disorders such as depression and/or anxiety and/or related disorders through neuromodulatory intervention that includes brain targets within the orbitofrontal cortex (OFC). This method includes the application of electrical stimulation through an electrical signal generator device where the distal end of the device comprises at least one stimulating electrode in contact with the OFC. The treatment system includes patient selection, implantation of at least one stimulating electrode in contact with the OFC, acute or chronic electrical stimulation of the OFC, and evaluation of the effects of stimulation on clinical symptoms and status.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: February 27, 2024
    Assignee: The Regents of the University of California
    Inventor: Edward F. Chang
  • Patent number: 11896816
    Abstract: An unattended approach can increase the reproducibility and safety of the treatment as the chance of over/under treating of a certain area is significantly decreased. On the other hand, unattended treatment of uneven or rugged areas can be challenging in terms of maintaining proper distance or contact with the treated tissue, mostly on areas which tend to differ from patient to patient (e.g. facial area). Delivering energy via a system of active elements embedded in a flexible pad adhesively attached to the skin offers a possible solution. The unattended approach may include delivering of multiple energies to enhance a visual appearance.
    Type: Grant
    Filed: February 16, 2023
    Date of Patent: February 13, 2024
    Assignee: BTL Healthcare Technologies A.S.
    Inventors: Tomás Schwarz, Lucia Jelínková, Vojtech Kubík
  • Patent number: 11890075
    Abstract: A portable complex sensor device for measuring multiple items of biometric information, according to the present invention, comprises: a plurality of electrodes for receiving the biometric information; a plurality of biometric information measuring circuits for measuring the biometric information received from the plurality of electrodes; a plurality of current sensors which are always supplied with power so as to sense electric current when an object to be measured contacts the electrodes; a wireless communication means for transmitting and receiving data to and from a smart phone; and a microcontroller for controlling the power supply of a battery by being operated in a sleep mode or an active mode on the basis of whether the current sensors have sensed the electric current.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: February 6, 2024
    Assignee: HEXACHECK INC.
    Inventors: In Deok Hwang, Chang Hwan Kim
  • Patent number: 11878167
    Abstract: An unattended approach can increase the reproducibility and safety of the treatment as the chance of over/under treating of a certain area is significantly decreased. On the other hand, unattended treatment of uneven or rugged areas can be challenging in terms of maintaining proper distance or contact with the treated tissue, mostly on areas which tend to differ from patient to patient (e.g. facial area). Delivering energy via a system of active elements embedded in a flexible pad adhesively attached to the skin offers a possible solution. The unattended approach may include delivering of multiple energies to enhance a visual appearance.
    Type: Grant
    Filed: May 19, 2022
    Date of Patent: January 23, 2024
    Assignee: BTL Healthcare Technologies A.S.
    Inventors: Tomás Schwarz, Lucia Jelínková, Vojtech Kubík
  • Patent number: 11878166
    Abstract: A system for monitoring or treating RLS or PLMD can include or use a leg-wearable electrostimulation device for acquiring auxiliary data from a subject at a first leg location at which the device is worn, the first leg-wearable electrostimulation device including or using a first neurostimulation delivery device, an impedance sensor configured for determining an impedance via the first and second skin electrodes, and an auxiliary sensor configured for detecting the auxiliary data of the first leg location at which the device is worn.
    Type: Grant
    Filed: November 15, 2022
    Date of Patent: January 23, 2024
    Assignee: NOCTRIX HEALTH, INC.
    Inventors: John Craig Colborn, Jonathan David Charlesworth, Shriram Raghunathan
  • Patent number: 11865359
    Abstract: A system and method for imaging or treating a disease in a human or animal body. The system provides to the human or animal body a pharmaceutical carrier including one or more phosphors which are capable of emitting ultraviolet or visible light into the body and which provide x-ray contrast. The system includes one or more devices which infuse a diseased site with a photoactivatable drug and the pharmaceutical carrier, an initiation energy source comprising an x-ray or high energy source which irradiates the diseased site with at least one of x-rays, gamma rays, or electrons to thereby initiate emission of said ultraviolet or visible light into the body, and a processor programmed to at least one of 1) produce images of the diseased site or 2) control a dose of said x-rays, gamma rays, or electrons to the diseased site for production of said ultraviolet or visible light at the diseased site to activate the photoactivatable drug.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: January 9, 2024
    Assignees: IMMUNOLIGHT, LLC., DUKE UNIVERSITY
    Inventors: Harold Walder, Frederic A. Bourke, Jr., Zakaryae Fathi, Wayne F. Beyer, Jr., Mark Dewhirst, Mark Oldham, Justus Adamson, Michael Nolan
  • Patent number: 11857785
    Abstract: Systems, devices and methods are provided for transcutaneously delivering energy impulses to bodily tissues for therapeutic purposes, such as for enhancing the body's bone healing process in spinal fusion patients. A therapeutic stimulator system comprises a housing for an energy source and a signal generator. The system further includes one or more electrodes coupled to the signal generator. A processor is coupled to the housing and configured to determine usage levels of the signal generator and/or motion data of the housing. The system may include a mobile device that allows the patient to input user status data, such as pain levels, and compare the user status data with the usage levels and/or the motion data, thereby improving patient compliance with a prescribed therapy regimen.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: January 2, 2024
    Assignee: Theragen, Inc.
    Inventors: Richard H. Pearce, Jon Christopher McAuliffe
  • Patent number: 11857788
    Abstract: Disclosed are apparatuses and methods for reducing or limiting blood loss and reducing bleed time in a subject by combined vagus and trigeminal stimulation. The apparatuses and methods may activate (e.g., electrically) one or more branches of the trigeminal nerve and may concurrently (at overlapping or near-overlapping time) independently activate the vagus nerve. This activation may be invasive or non-invasive.
    Type: Grant
    Filed: January 4, 2023
    Date of Patent: January 2, 2024
    Assignee: The Feinstein Institutes for Medical Research
    Inventor: Kirk R. Manogue
  • Patent number: 11850056
    Abstract: Systems and methods for remote therapy and patient monitoring are provided. A method comprises contacting an outer skin surface of a patient with a contact surface of a stimulator and transmitting an electrical impulse from the stimulator transcutaneously through the outer skin surface to a nerve within the patient. Data related to parameters of the electrical impulse applied to the nerve is stored and transmitted to a remote source. The data may include duration of treatment, amplitude of the electrical impulse, compliance with a prescribed therapy regimen or other relevant data related to the therapy. The method may further include collecting patient status data, such as symptoms of a medical condition (e.g., severity of a headache) before, during and/or after stimulation. The patient status data is correlated with the treatment data to monitor compliance and/or the effectiveness of the therapy.
    Type: Grant
    Filed: July 27, 2022
    Date of Patent: December 26, 2023
    Assignee: ElectroCore, Inc.
    Inventors: Bruce J. Simon, Joseph P. Errico
  • Patent number: 11839759
    Abstract: An electrical stimulation training and neuromuscular rehabilitation system including a machine-washable stimulation suit with multiple electrodes to provide controlled stimulation of various muscle groups is provided. The stimulation suit may also include one or more integrated biosensors to provide diagnostic capability in addition to stimulation. The system may also include a software platform executable on a user computing device (such as a tablet) that may facilitate control of the stimulation programs (e.g., intensity level, duration, isolation of individual muscle groups vs. full body stimulation) of one or more stimulation suits by the wearer or a fitness practitioner or trainer and/or that may facilitate intervention by a medical provider through a remote telemedicine platform.
    Type: Grant
    Filed: March 21, 2023
    Date of Patent: December 12, 2023
    Assignee: NEURO20 TECHNOLOGIES CORP.
    Inventors: Michael Howard Finkelstein, Dennis Michael Schmitt, Jana Schmitt
  • Patent number: 11833342
    Abstract: A catheter pump is disclosed herein. The catheter pump can include a catheter assembly that comprises a drive shaft and an impeller coupled to a distal end of the drive shaft. A driven assembly can be coupled to a proximal end of the drive shaft within a driven assembly housing. The catheter pump can also include a drive system that comprises a motor and a drive magnet coupled to an output shaft of the motor. The drive system can include a drive assembly housing having at least one magnet therein. Further, a securement device can be configured to prevent disengagement of the driven assembly housing from the drive assembly housing during operation of the pump.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: December 5, 2023
    Assignee: TC1 LLC
    Inventors: Adam R. Tanner, Richard L Keenan, Doug M. Messner, Michael R. Butler
  • Patent number: 11826565
    Abstract: An unattended approach can increase the reproducibility and safety of the treatment as the chance of over/under treating of a certain area is significantly decreased. On the other hand, unattended treatment of uneven or rugged areas can be challenging in terms of maintaining proper distance or contact with the treated tissue, mostly on areas which tend to differ from patient to patient (e.g. facial area). Delivering energy via a system of active elements embedded in a flexible pad adhesively attached to the skin offers a possible solution. The unattended approach may include delivering of multiple energies to enhance a visual appearance.
    Type: Grant
    Filed: September 9, 2022
    Date of Patent: November 28, 2023
    Assignee: BTL Healthcare Technologies A.S.
    Inventors: Tomás Schwarz, Lucia Jelínková
  • Patent number: 11819689
    Abstract: A medical procedure for treating human male and female patients suffering from erectile or sexual dysfunction, respectively, with focused extracorporeal shockwave therapy applied to strategic, gender-specific anatomical regions to improve sexual function. Some or all of the gender-specific anatomical regions may be anesthetized using a topical or local anesthetic, and focused extracorporeal shockwaves are applied to the anatomical regions at predetermined bar values, frequencies, and number of shockwave pulses, based on the severity of the sexual dysfunction. Focused extracorporeal shockwaves may be used in addition to convention methods of treating both erectile and sexual dysfunction.
    Type: Grant
    Filed: May 2, 2023
    Date of Patent: November 21, 2023
    Inventors: Richard Gaines, Vincent Liguori